Acute Stress Response in Children with Meningococcal Sepsis: Important Differences in the Growth Hormone/insulin-like Growth Factor I Axis Between Nonsurvivors and Survivors
Overview
Authors
Affiliations
Septic shock is the most severe clinical manifestation of meningococcal disease and is predominantly seen in children under 5 yr of age. Very limited research has been performed to elucidate the alterations of the GH/IGF-I axis in critically ill children. We evaluated the GH/IGF-I axis and the levels of IGF-binding proteins (IGFBPs), IGFBP-3 protease, glucose, insulin, and cytokines in 27 children with severe septic shock due to meningococcal sepsis during the first 3 d after admission. The median age was 22 months (range, 4-185 months). Eight patients died. Nonsurvivors had extremely high GH levels that were significant different compared with mean GH levels in survivors during a 6-h GH profile (131 vs. 7 mU/liter; P < 0.01). Significant differences were found between nonsurvivors and survivors for the levels of total IGF-I (2.6 vs. 5.6 nmol/liter), free IGF-I (0.003 vs. 0.012 nmol/liter), IGFBP-1 (44.3 vs. 8.9 nmol/liter), IGFBP-3 protease activity (61 vs. 32%), IL-6 (1200 vs. 50 ng/ml), and TNFalpha (34 vs. 5.3 pg/ml; P < 0.01). The pediatric risk of mortality score correlated significantly with levels of IGFBP-1, IGFBP-3 protease activity, IL-6, and TNFalpha (r = +0.45 to +0.69) and with levels of total IGF-I and free IGF-I (r = -0.44 and -0.55, respectively). Follow-up after 48 h in survivors showed an increased number of GH peaks, increased free IGF-I and IGFBP-3 levels, and lower IGFBP-1 levels compared with admission values. GH levels and IGFBP-1 levels were extremely elevated in nonsurvivors, whereas total and free IGF-I levels were markedly decreased and were accompanied by high levels of the cytokines IL-6 and TNFalpha. These values were different from those for the survivors. Based on these findings and literature data a hypothetical model was constructed summarizing our current knowledge and understanding of the various mechanisms.
Mehdi S, Qureshi M, Pervaiz S, Kumari K, Saji E, Shah M Mol Med. 2025; 31(1):16.
PMID: 39838305 PMC: 11752782. DOI: 10.1186/s10020-025-01074-z.
Kocadag H, Weischendorff S, De Pietri S, Nielsen C, Rathe M, Als-Nielsen B Int J Mol Sci. 2024; 25(17).
PMID: 39273528 PMC: 11394967. DOI: 10.3390/ijms25179582.
Experimental Autoimmune Encephalomyelitis Influences GH-Axis in Female Rats.
Zivkovic A, Trifunovic S, Savic D, Milosevic K, Lavrnja I Int J Mol Sci. 2024; 25(11).
PMID: 38892024 PMC: 11172041. DOI: 10.3390/ijms25115837.
Nutritional Considerations for the Neonate With Congenital Heart Disease.
Mills K, Kim J, Fogg K, Goldshtrom N, Graham E, Kataria-Hale J Pediatrics. 2022; 150(Suppl 2).
PMID: 36317972 PMC: 11827043. DOI: 10.1542/peds.2022-056415G.
Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation.
Aissi James S, Klein T, Lebreton G, Nizard J, Chommeloux J, Brechot N Crit Care. 2022; 26(1):96.
PMID: 35392980 PMC: 8988404. DOI: 10.1186/s13054-022-03969-3.